0000950170-24-057098.txt : 20240509
0000950170-24-057098.hdr.sgml : 20240509
20240509163040
ACCESSION NUMBER: 0000950170-24-057098
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240507
FILED AS OF DATE: 20240509
DATE AS OF CHANGE: 20240509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liu Hui
CENTRAL INDEX KEY: 0001790518
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37773
FILM NUMBER: 24931228
MAIL ADDRESS:
STREET 1: C/O MERUS N.V.
STREET 2: YALELAAN 62
CITY: UTRECHT
STATE: P7
ZIP: 3584 CM
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merus N.V.
CENTRAL INDEX KEY: 0001651311
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
BUSINESS PHONE: 31 030 253 8800
MAIL ADDRESS:
STREET 1: YALELAAN 62
CITY: 3584 CM UTRECHT
STATE: P7
ZIP: 3584 CM
FORMER COMPANY:
FORMER CONFORMED NAME: Merus B.V.
DATE OF NAME CHANGE: 20150819
4
1
ownership.xml
4
X0508
4
2024-05-07
0001651311
Merus N.V.
MRUS
0001790518
Liu Hui
C/O MERUS N.V.
UPPSALALAAN 17
UTRECHT
P7
3584 CT
NETHERLANDS
false
true
false
false
EVP, CBO & Head of Merus US
false
Share Option (right to buy)
36.09
2024-05-07
4
A
false
107300
0
A
2034-01-31
Common Shares
107300
107300
D
On February 1, 2024, the Board of Directors approved the grant of options to purchase the common shares, at an exercise price of $36.09 per share, subject to the Company's general meeting resolving upon, and the Board having implemented through an amendment to the Company's articles of association, an increase in the authorized share capital sufficient to satisfy the award set forth (the "Shareholder Approval Condition"). On May 7, 2024, the shareholders approved the amendment to the Company's articles of association, including the increase in the authorized share capital satisfying the Shareholder Approval Condition.
Options vest over a four-year period from January 1, 2024. 25% vest on January 1, 2025 and in 36 equal monthly installments thereafter.
/s/ Peter Silverman as attorney-in-fact
2024-05-09